Lyon, France

Abdelkamel Chettab

This inventor holds 1 USPTO granted patent and 1 published patent application and 1 EPO patent. Top assignees: Centre Leon Berard, Centre National De La Recherche Scientifique, Hospices Civils De Lyon. Active years: 2025.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Abdelkamel Chettab. Retrieved from https://idiyas.com/inventor/abdelkamel-chettab

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 1 

% Patents Active = 100.0

 

Average Co-Inventor Count = 2.0

ph-index = 1


Company Filing History:


Years Active: 2025

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Abdelkamel Chettab: Innovator in Anti-Tumor Therapy

Introduction

Abdelkamel Chettab is a notable inventor based in Lyon, France. He has made significant contributions to the field of pharmaceutical formulations, particularly in anti-tumor therapies. His innovative work has the potential to impact cancer treatment positively.

Latest Patents

Chettab holds a patent for a "Liposomal formulation of bacterial lipopolysaccharide combined with a cytotoxic agent, and use thereof in anti-tumour therapy." This invention relates to a pharmaceutical combination product that aims to enhance the efficacy of anti-tumor treatments. The patent highlights the importance of combining specific agents to improve therapeutic outcomes in cancer patients. He has 1 patent to his name.

Career Highlights

Throughout his career, Chettab has worked with prestigious institutions, including the Centre National de la Recherche Scientifique and Hospices Civils de Lyon. His experience in these organizations has allowed him to collaborate with leading experts in the field and contribute to groundbreaking research.

Collaborations

One of his notable collaborators is Charles Dumontet. Their partnership has likely fostered innovative ideas and advancements in cancer therapy.

Conclusion

Abdelkamel Chettab's work in developing novel anti-tumor therapies showcases his dedication to improving cancer treatment. His contributions to pharmaceutical science are commendable and reflect his commitment to innovation in healthcare.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…